Tyrosinase Inhibition and Kinetic Details of Puerol A Having But-2-Enolide Structure from Amorpha fruticosa.
Jeong Ho KimDa Hyun JangKi Won LeeKwang Dong KimAbdul Bari ShahKamila ZhumanovaKi Hun ParkPublished in: Molecules (Basel, Switzerland) (2020)
Puerol A (1) from Amorpha fruticosa showed highly potent inhibition against both monophenolase (IC50 = 2.2 μM) and diphenolase (IC50 = 3.8 μM) of tyrosinase. We tried to obtain a full story of enzyme inhibitory behavior for inhibitor 1 because the butenolide skeleton has never been reported as a tyrosinase inhibitor. Puerol A was proved as a reversible, competitive, simple slow-binding inhibitor, according to the respective parameters; k3 = 0.0279 μM-1 min-1 and k4 = 0.003 min-1. A longer lag-phase and a reduced static-state activity of the enzyme explained that puerol A had a tight formation of the complex with Emet. Dose-dependent inhibition was also confirmed by high-performance liquid chromatography (HPLC) analysis using N-acetyl-l-tyrosine as a substrate, which was completely inhibited at 20 μM. A high binding affinity of 1 to tyrosinase was confirmed by fluorescence quenching analysis. Moreover, puerol A decreased melanin content in the B16 melanoma cell dose-dependently with an IC50 of 11.4 μM.
Keyphrases
- high performance liquid chromatography
- simultaneous determination
- tandem mass spectrometry
- mass spectrometry
- solid phase extraction
- ms ms
- blood brain barrier
- binding protein
- stem cells
- cell therapy
- single molecule
- liquid chromatography
- transcription factor
- bone marrow
- mesenchymal stem cells
- high resolution
- capillary electrophoresis